Development of in vivo μCT evaluation of neovascularisation in tissue engineered bone constructs

被引:56
|
作者
Bolland, B. J. R. F. [1 ]
Kanczler, J. M. [1 ]
Dunlop, D. G. [1 ]
Oreffo, R. O. C. [1 ]
机构
[1] Univ Southampton, Inst Dev Sci, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
neovascularisation; allograft; mu CT; tissue engineering; impaction bone grafting; adult human bone marrow stromal cells;
D O I
10.1016/j.bone.2008.02.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to an increasing aging population the need for innovative approaches to aid skeletal repair and reconstruction is a significant socio-economic increasing problem. The emerging discipline of tissue engineering has sort to augment the growth and repair of bone loss particularly in areas of trauma, degeneration and revision surgery. However, the initiation and development of a fully functional vascular network are critical for bioengineered bone to repair large osseous defects, whether the material is osteosynthetic (poly (D,L)-lactic acid, PLA) or natural bone allograft. Quantification and three-dimensional visualization of new vessel networks remain a problem in bone tissue engineering constructs. A novel technique utilising a radio-opaque dye and micro-computed tomography (mu CT) has been developed and applied to study angiogenesis in an impaction bone graft model. Tissue-engineered constructs combining human bone marrow stromal cells (HBMSC) with natural allograft and synthetic grafts (PLA) were impacted and implanted into the subcutis of MF-1 nu/nu mice for a period of 28 days. Microfil consisting of radio-opaque polymer was perfused through the mice and scanned using a Bench Top CT system for microcomputed tomography. Analysis of three-dimensional mu CT reconstructions demonstrated an increase in vessel volume and vessel number in the impacted scaffolds/HBMC compared to scaffolds alone. Vessel volume: allograft/HBMSC = 0.57 mm(3) +/- 0.19; allograft = 0.04 mm(3) +/- 0.04; PLA/HBMSC = 1.19 mm(3) +/- 0.31: and PLA = 0.12 mm(3) +/- 0.01. Penetrating vessel number: allograft/HBMSC = 22.33 3.21; allograft = 3.67 +/- 1.153; PLA/HBMSC = 32.67 +/- 8.33; and PLA = 7.67 +/- 3.06. Type 1 collagen and von Willebrand factor immunohistochemistry in scaffold/HBMSC constructs indicated the osteogenic cell phenotype, and new blood vessel formation respectively. Contrast-enhanced 3D reconstructions facilitated the visualization and quantification of neovascularisation. This novel technique has been used to demonstrate neovascularisation in impacted tissue engineered constructs providing a facile approach with wide experimental application. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
  • [21] Development and Evaluation of an In Vivo Tissue Engineered Blood Vessel in a Porcine Model
    Rothuizen, C.
    Damanik, F.
    Lavrijsen, T.
    Visser, M.
    Hamming, J.
    Lalai, R.
    Duijs, J.
    Van Zonneveld, A.
    Hoefer, I.
    Van Blitterswijk, C.
    Rabelink, T.
    Moroni, L.
    Rotmans, J.
    TISSUE ENGINEERING PART A, 2015, 21 : S82 - S82
  • [22] THE DEVELOPMENT OF THE COLLAGEN FIBRE NETWORK IN TISSUE-ENGINEERED CARTILAGE CONSTRUCTS IN VIVO. ENGINEERED CARTILAGE REORGANISES FIBRE NETWORK
    Paetzold, H.
    Goepfert, C.
    Huber, G.
    Hoenig, E.
    Poertner, R.
    Schilling, A. F.
    Meenen, N. M.
    Morlock, M. M.
    EUROPEAN CELLS & MATERIALS, 2012, 23 : 209 - 221
  • [23] Nondestructive evaluation of osteogenic differentiation in tissue-engineered constructs
    Hong, L
    Peptan, IA
    Xu, HH
    Magin, RL
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2006, 24 (05) : 889 - 897
  • [24] Vascularization of tissue engineered constructs
    Pullens, R. A. A.
    Bouten, C. V. C.
    Baaijens, F. P. T.
    Post, M. J.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 77 - 77
  • [25] Pattern of Bone Generation after Irradiation in Vascularized Tissue Engineered Constructs
    Eweida, Ahmad
    Fathi, Ibrahim
    Eltawila, Ahmed M.
    Elsherif, Ahmad M.
    Elkerm, Yasser
    Harhaus, Leila
    Kneser, Ulrich
    Sakr, Mahmoud F.
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2018, 34 (02) : 130 - 137
  • [26] Bioreactor Development for the Study of Angiogenesis within Tissue Engineered Constructs
    Frese, J.
    Motejlek, K.
    Schmitz-Rode, T.
    Neulen, J.
    Jockenhoevel, S.
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS, 2009, 25 (10): : 150 - +
  • [27] Tissue engineering strategies for in vivo neovascularisation
    Ennett, AB
    Mooney, DJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (08) : 805 - 818
  • [28] Tissue-engineered skin substitutes:: from in vitro constructs to in vivo applications
    Auger, FA
    Berthod, F
    Moulin, W
    Pouliot, R
    Germain, L
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 39 : 263 - 275
  • [29] Ischemia is a prime but not the only cause of hMSC death in tissue engineered constructs in vivo
    Logeart-Avramoglou, D.
    Becquart, P.
    Cambon-Binder, A.
    Bourguignon, M.
    Bensidhoum, M.
    Petite, H.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 375 - 375
  • [30] Decelerated vascularization in tissue-engineered constructs in association with diabetes mellitus in vivo
    Schumann, Paul
    Lindhorst, Daniel
    Kampmann, Andreas
    Gellrich, Nils-Claudius
    Krone-Wolf, Sonja
    Meyer-Lindenberg, Andrea
    von See, Constantin
    Gander, Thomas
    Lanzer, Martin
    Rucker, Martin
    Essig, Harald
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (07) : 855 - 864